The FDA has released a new draft guidance: Internet/Social Media Platforms with Character Space Limitations—Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices (“FDA Guidance”). Klick Health has crafted a POV on what this means for healthcare marketers in the US.
In this POV we look at the draft guidance and cover:
- No guarantees – if your project doesn’t fit then don’t use the channels
- Google AdWords with Enhanced Sitelinks – it looks like the FDA has missed part of the technology and this raises questions
- Is the “One Click” rule returning? – it is a rule that never existed, so it can’t return, but links are now being accepted by the FDA
- URL shorteners – these are being accepted for space-limited channels
- Generic names – still need to be in the messaging
- Dosage forms – don’t need to be in the message but do need to be on the destination link
This is one of two draft guidances that the FDA released yesterday. See also FDA draft guidance on correcting misinformation.